Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Sherman

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
The Psychoanalytic Quarterly|July 19, 2016
FROM ID TO INTERSUBJECTIVITY: TALKING ABOUT THE TALKING CURE WITH MASTER CLINICIANS. By Diana T. KennyEric Sherman
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Combined modality treatment of squamous cell cancer of the head and neckJohn Devlin, Eric Sherman
Seminars in Radiation Oncology|June 13, 2012
The role of external beam radiation and targeted therapy in thyroid cancerJames Brierley, Eric Sherman
Clinical Advances in Hematology & Oncology : H&O|February 18, 2011
Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancerAlan L Ho, Eric Sherman
JAMA Oncology|July 24, 2020
The Importance of Locoregional Therapy in Metastatic Nasopharyngeal CancerNadeem Riaz, Eric Sherman, Nancy Lee
Clinical Endocrinology|February 2, 2019
Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapyMona M Sabra, Eric Sherman, Robert Michael Tuttle
Cureus|February 11, 2026
Uncommon Neuro-Ophthalmologic Findings in Pediatric Lyme DiseaseUmme Habiba Fatima Syeda, Nika Bakshi, Eric Sherman
Clinical Lung Cancer|May 27, 2008
Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599Robert A Somer, Eric Sherman, Corey J Langer
The Journal of Clinical Endocrinology and Metabolism|March 2, 2012
Risk of rash in cancer patients treated with vandetanib: systematic review and meta-analysisAlyx C Rosen, Shenhong Wu, Amelia Damse, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 19, 2007
Transoral robotic surgery: radical tonsillectomyGregory S Weinstein, Bert W O'Malley, Wendy Snyder, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
The Psychoanalytic Quarterly|July 19, 2016
FROM ID TO INTERSUBJECTIVITY: TALKING ABOUT THE TALKING CURE WITH MASTER CLINICIANS. By Diana T. KennyEric Sherman
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Combined modality treatment of squamous cell cancer of the head and neckJohn Devlin, Eric Sherman
Seminars in Radiation Oncology|June 13, 2012
The role of external beam radiation and targeted therapy in thyroid cancerJames Brierley, Eric Sherman
Clinical Advances in Hematology & Oncology : H&O|February 18, 2011
Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancerAlan L Ho, Eric Sherman
JAMA Oncology|July 24, 2020
The Importance of Locoregional Therapy in Metastatic Nasopharyngeal CancerNadeem Riaz, Eric Sherman, Nancy Lee
Clinical Endocrinology|February 2, 2019
Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapyMona M Sabra, Eric Sherman, Robert Michael Tuttle
Cureus|February 11, 2026
Uncommon Neuro-Ophthalmologic Findings in Pediatric Lyme DiseaseUmme Habiba Fatima Syeda, Nika Bakshi, Eric Sherman
Clinical Lung Cancer|May 27, 2008
Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599Robert A Somer, Eric Sherman, Corey J Langer
The Journal of Clinical Endocrinology and Metabolism|March 2, 2012
Risk of rash in cancer patients treated with vandetanib: systematic review and meta-analysisAlyx C Rosen, Shenhong Wu, Amelia Damse, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 19, 2007
Transoral robotic surgery: radical tonsillectomyGregory S Weinstein, Bert W O'Malley, Wendy Snyder, et al.
Pageof 10